Open access · OA
via OpenAlex
Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells
Patrícia de Souza Nascimento, Gilda Alves, Wolfgang Fiedler
Oncology Reports · 2006 · ▲ 41 citations
Abstract
Human telomerase is a ribonucleoprotein complex composed of at least the reverse catalytic transcriptase hTERT and RNA component hTR. The enzyme stabilizes telomere(definition) length and thereby contributes to unlimited cell proliferation, i.e. immortality. Reactivation of telomerase activity during carcinogenesis is a common hallmark in most human tumor types. Consequently, telomerase is an attractive molecular target toward which to direct cancer therapeutic agents. RNA interference (RNAi) has been shown to be an effective method for inhibiting the expression of a given gene in human cells by targeting with short duplex RNA (short-interfering RNA or siRNA). Thus, we evaluated the ability of siRNAs to inhibit telomerase activity in the HT29 immortal human colorectal adenocarcinoma cell line as a model for colorectal carcinogenesis. By transient expression of a specific siRNA directed against hTERT, we reduced telomerase activity in the transfected cells. Moreover, telomere lengths were reduced in cells stably expressing this particular RNA sequence, cloned as an shRNA into an eukaryotic expression vector. The cell clone that displayed a telomerase-negative phenotype showed dramatically reduced telomere lengths and stopped proliferation. We observed that the vector was integrated into the cell genome and, despite telomere shortening, cells retained their MSI phenotype. We conclude that we have developed a potent telomerase inhibitor leading to cell death.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3892/or.16.2.423
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Nascimento, P.D.S., Alves, G., & Fiedler, W. (2006). Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells. <em>Oncology Reports</em>. https://doi.org/10.3892/or.16.2.423
Vancouver
Nascimento PDS, Alves G, Fiedler W. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells. Oncology Reports. 2006. doi:10.3892/or.16.2.423.
BibTeX
@article{patrcia2006Telome,
title = {Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells},
author = {Patrícia de Souza Nascimento and Gilda Alves and Wolfgang Fiedler},
journal = {Oncology Reports},
year = {2006},
doi = {10.3892/or.16.2.423},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bioorganic & Medicinal Chemistry Reports 2020
Open access · OA
Telomere, telomerase and telomerase inhibitors
Medicinal Research Reviews 2020
Preprint · OA
Targeting telomerase for its advent in cancer therapeutics
Genes & Development 1999
Preprint · OA
Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
British Journal of Cancer 2004
Open access · CC-BY
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
Progress in molecular biology and translational science 2014
Citation only
Telomere and Telomerase Biology
The Journal of Infectious Diseases 2013
Citation only